-The Hindu Institutional deliveries are up in India, but breastfeeding within the first hour of birth needs to keep pace Despite institutional delivery being as high as nearly 79% nationally, the number of children in India breastfed within one hour of birth is less than 42% — near 43% in urban areas and 41% in rural India, according to the National Family Health Survey 4 (NFHS-4) data released a few days ago....

-The Hindu Business Line The effectiveness of the revised Maternity Benefit Act depends on its proper implementation India now lags only Canada and Norway in the level of maternity benefits such as paid time off work extended to women. India’s statutory maternity leave is now the third best in the world and is certainly something to be proud of. However, the law is no assurance that the situation of working women will...

-Hindustan Times India’s performance in the recently released Global Hunger Index (GHI) report is tragic. The country which is one of the largest producers of cereals, vegetables and fruits in the world, ranks 97 among 118 countries and is home to over 184 million undernourished people. India also pays a very heavy price for vitamin and mineral deficiencies, often called “hidden hunger”, as it loses $12 billion in gross domestic product...

-Hindustan Times The last few weeks have seen a spate of government notifications making Aadhaar mandatory for receiving the benefits of government programmes. The most recent orders relate to an Aadhaar requirement for children to access schools (even under their fundamental right to education), mid-day meals, supplementary nutrition (ICDS) and scholarships. These directives raise a number of ethical as well as practical questions, besides violating children’s right to education, nutrition and...

-The Hindu In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, innovator of the drug, filed a suit against the Indian Food & Drug Administration (FDA) to block its sale. The action firmly put their profits ahead of the lives of women with breast cancer. Roche effectively embroiled India’s...